Compound Detail
CHEMBL5186691
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5186691 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | VSNORRKMXFUQBL-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
356.4
MW (Da)
5.24
ALogP
5
HBA
1
HBD
42.7
PSA (Ų)
0.47
QED
1
Ro5 Violations
2
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 7.24
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| HT-1080 CHEMBL614580 | EC50 | 7.24 | 7.24 | 58.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HT-1080 | EC50 | = | 58.0 | nM | 7.24 | Anti-ferroptotic activity against Erastin-induced ferroptosis in human HT-1080 c... | 35907606 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 35907606 | 10.1016/j.bmcl.2022.128911 | HT-1080 | 1 |
Data from ChEMBL 36 via Core Engine